Browse
Explore conditions, clinical trials, and the organisations running them.
7477 conditions with clinical trials.
- Ovarian serous adenocarcinoma 2988 trials
- Esophageal adenocarcinoma 2987 trials
- Metastatic squamous cell carcinoma 2987 trials
- Thyroid cancer 2986 trials
- Malignant ovarian serous tumor 2985 trials
- Testicular leukemia 2983 trials
- Hypopharynx cancer 2981 trials
- Indolent B-cell non-Hodgkin lymphoma 2981 trials
- Hypopharyngeal carcinoma 2980 trials
- Skin carcinoma 2976 trials
- Carcinoma of the ampulla of vater 2970 trials
- Cutaneous melanoma 2969 trials
- Fallopian tube carcinoma 2968 trials
- Hypopharynx squamous cell carcinoma 2967 trials
- Renal cell adenocarcinoma 2964 trials
- Ampulla of vater cancer 2963 trials
- Anal carcinoma 2960 trials
- Colon adenocarcinoma 2958 trials
- Childhood choroid plexus carcinoma 2957 trials
- Metastatic malignant neoplasm in the colon 2957 trials
- Nonpapillary renal cell carcinoma 2957 trials
- Salivary gland cancer 2957 trials
- Ampulla of vater adenocarcinoma 2956 trials
- Pineal region yolk sac tumor 2955 trials
- Anus cancer 2954 trials
- Childhood brain germinoma 2951 trials
- Childhood immature teratoma of ovary 2950 trials
- Aggressive B-cell non-Hodgkin lymphoma 2949 trials
- Breast carcinoma in situ 2948 trials
- Gastroesophageal cancer 2948 trials
- Periampullary adenocarcinoma 2947 trials
- Pediatric intraocular retinoblastoma 2946 trials
- Pediatric high-grade glioma 2943 trials
- Obesity disorder 2941 trials
- Lip and oral cavity squamous cell carcinoma 2940 trials
- Urinary system neoplasm 2940 trials
- Plasma cell neoplasm 2939 trials
- Hereditary nonpolyposis colon cancer 2938 trials
- Liver sarcoma 2938 trials
- Salivary gland carcinoma 2938 trials
- Hilar cholangiocarcinoma 2937 trials
- Undifferentiated (embryonal) sarcoma 2937 trials
- Distal biliary tract carcinoma 2936 trials
- Childhood oligodendroglioma 2934 trials
- Lynch syndrome 2933 trials
- Breast ductal adenocarcinoma 2932 trials
- Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype 2930 trials
- Endometrioid adenocarcinoma 2930 trials
- Ocular cancer 2930 trials
- Perihilar intrahepatic cholangiocarcinoma 2929 trials